Available Until 5/2/2026

Delirium in the PICU and NICU

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists - Pediatrics

ACPE Activity Number: 0204-0000-23-084-H01-P 
Release Date:  5/2/2023
Expiration Date: 5/2/2026 
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEU)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

This webinar will discuss the PANDEM Guidelines including preferred sedation, pain, delirium and withdrawal screening tools and will review a recommended pharmacotherapy plan for analgesia and sedation for a patient in the PICU based on patient characteristics. 

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of healthcare providers in regards to the management of delirium in the pediatric and neonatal intensive care unit. 

After completing this activity, the learner should be able to… 

1. Identify modifiable and non-modifiable risk factors for ICU delirium.  

2. Recall PANDEM guideline recommendations for the assessment and management of ICU delirium in infants and children.  

3. Discuss screening tools and pharmacologic options for treating ICU delirium in the pediatric population.   

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Peter N. Johnson, PharmD, BCPPS, FPPAG, FCCM, FASHP
Professor and President’s Associate Presidential Professor
University of Oklahoma College of Pharmacy and Clinical Pharmacy Specialist--CICU
Oklahoma Children’s Hospital at OU Health
Oklahoma City,


Morgan King, PharmD, BCPPS
Clinical Pharmacy Specialist
Cleveland Clinic Fairview Hospital
Cleveland, OH

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.